Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Viemed HealthcareVMD +2.97%88 EV-to-EBIT is 20.61 as of Jul. 28, 2026, which is 10% above its 10-year median of 18.82. GuruFocus rates VMD with a GF Score™ of 88/100 and a GF Value™ of $10.99 (Fairly Valued). The stock has 7 warning signs investors should review. Among 466 Medical Devices & Instruments companies, Viemed Healthcare ranks worse than 55.79% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Viemed Healthcare's Enterprise Value for the quarter that ended in Mar. 2026 was $359.5 Mil.
Viemed Healthcare's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $22.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viemed Healthcare EV-to-EBIT Related Terms
Viemed Healthcare EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Viemed Healthcare's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Viemed Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viemed Healthcare EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Viemed Healthcare's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Viemed Healthcare's EV-to-EBIT falls into.
Viemed Healthcare's current Enterprise Value is $469.3 Mil.
Viemed Healthcare's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $22.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viemed Healthcare (VMD) has a EV-to-EBIT of 20.61 as of Jul. 28, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Viemed Healthcare and its competitors. This is 10% above median its historical median of 18.82. Over the past decade, Viemed Healthcare's EV-to-EBIT has ranged from 8.05 to 56.20. According to the industry distribution chart, Viemed Healthcare ranks #260 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 55.8%.
Is Viemed Healthcare's EV-to-EBIT too high?
Viemed Healthcare's current EV-to-EBIT of 20.61 is 10% above median its 10-year median of 18.82. Over the past 10 years, this metric has ranged from a low of 8.05 to a high of 56.20. The Medical Devices & Instruments industry median EV-to-EBIT is 18.67. Viemed Healthcare's value of 20.61 is 10.4% above this industry median. Based on the distribution chart, Viemed Healthcare ranks #260 out of 466 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Viemed Healthcare has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Viemed Healthcare's EV-to-EBIT compare to OFIX and VREX?
According to the Medical Devices & Instruments industry distribution chart, Viemed Healthcare ranks #260 out of 466 companies for EV-to-EBIT. This places Viemed Healthcare in the lower half of its industry. The industry median EV-to-EBIT is 18.67. Viemed Healthcare's value of 20.61 is 10.4% above this benchmark. Historically, Viemed Healthcare's own EV-to-EBIT has ranged from 8.05 to 56.20 over the past decade. While the company's 10-year median is 18.82 vs. the industry median of 18.67, Viemed Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.67, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viemed Healthcare's current EV-to-EBIT of 20.61 is 10.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Viemed Healthcare and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viemed Healthcare's current EV-to-EBIT is 20.61, which is 10% above median its own 10-year median of 18.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viemed Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Viemed Healthcare (VMD) is currently considered Fairly Valued. The stock's GF Value™ is $10.99, compared to a current price of $12.12 — trading 10.3% above its estimated fair value. The current EV-to-EBIT is 20.61, which is 10% above median its 10-year median of 18.82 and 10.4% above the Medical Devices & Instruments industry median of 18.67. Viemed Healthcare's overall GF Score™ is 88/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Viemed Healthcare (VMD), the current EV-to-EBIT is 20.61 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Viemed Healthcare (VMD) Overvalued in 2026?
Based on GuruFocus' analysis, Viemed Healthcare stock appears to be overvalued.
The current stock price of $12.12 is trading 10.3% above its estimated GF Value™ of $10.99.
GuruFocus considers Viemed Healthcare to be Fairly Valued.
Key valuation signals for VMD:
EV-to-EBIT: 20.61 (10% above median its 10-year median of 18.82)
GF Value™: $10.99 vs. price of $12.12 (10.3% above fair value)
Industry Position: 10.4% above the Medical Devices & Instruments median (#260 of 466)
No single metric tells the full story. See the VMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
88GF Score
Get the complete analysis for VMD
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VMD has been successfully added to your 
